DANIELLE WILLIAMSON: Open Payments
NPI 1457689275 · DADE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 23 payments from 12 companies in 2025. Trend: 2023 $304 · 2024 $231 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $120 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Amgen Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $50 |
| MERZ NORTH AMERICA, INC. | 1 | $50 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, TRELEGY ELLIPTA, OTEZLA, Cologuard Collection Kit, Wegovy, GARDASIL 9, LUX-Dx Insertable Cardiac Monitor, IMFINZI.
Industry payments across FL — which companies pay providers there.
